{"id":"W4403312140","doi":"10.1016/j.jhepr.2024.101232","title":"Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"European Association for the Study of the Liver; National Institute for Health and Care Research; NIHR Imperial Biomedical Research Centre; Cancer Research UK","keywords":"Atezolizumab; Bevacizumab; Oncology; Medicine; Internal medicine; Cancer; Nivolumab; Chemotherapy; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000716186,0.0001287767,0.0002398359,0.000486798,0.0001993948,0.0005265102,0.0002262596,0.0002596772,0.000935606],"category_scores_gemma":[0.002214512,0.00007726346,0.0003599337,0.0005790485,0.0002080211,0.0004073064,0.0003649818,0.0004358075,0.0001130601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004032318,"about_ca_system_score_gemma":0.0003050597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001079131,"about_ca_topic_score_gemma":0.001278671,"domain_scores_codex":[0.9995676,0.0001213924,0.00006050645,0.00009531119,0.00006761037,0.00008766747],"domain_scores_gemma":[0.9971229,0.0003252822,0.001870339,0.0001151431,0.000161491,0.0004047068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003560577,0.00005368718,0.9968457,0.000008165784,0.00002897408,0.00007923842,0.00005458732,0.00008287975,0.0001918965,0.00001430597,0.00005463107,0.002229932],"study_design_scores_gemma":[0.00002075356,0.0005056754,0.9980501,0.000007808955,0.00002175751,0.000516596,0.0001691107,0.0003497476,0.0001706057,0.00003852151,0.0001443191,0.00000509992],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995862,0.0001260634,0.00004067496,0.00002052032,0.000001619017,0.000004217385,0.00008876337,0.000001577606,0.0001303557],"genre_scores_gemma":[0.9997396,0.00002710395,0.00002014657,0.000008145495,0.000003382884,0.000003455407,0.0001678338,7.763267e-7,0.0000296743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001079131,"threshold_uncertainty_score":0.003787577,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03054378279230424,"score_gpt":0.3042937490793094,"score_spread":0.2737499662870052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}